Follow the Exits is the first comprehensive analysis of 25 years of women’s health exits, capturing $91B+ in realized value, accelerating momentum, and clear proof that women’s health is a scaled, high-performing healthcare market. What’s new is not the momentum, it’s the measurement.
Download Now
The data show that women’s health is not a niche of boutique segment, but a core driver of innovation across diagnostics, oncology, and chronic care. Despite being historically undercapitalized at the early stage, women’s health companies have demonstrated strong capital efficiency, repeat strategic acquisition interest, and increasing exit scale over time.
